August 17, 2009

HELIX BIOPHARMA ANNOUNCES THE APPOINTMENT OF KAZIMIERZ ROSZKOWSKI-ŚLIŻ, M.D., PH.D., TO ITS BOARD OF DIRECTORS (PDF)

(AURORA, Ontario) – Helix BioPharma Corp. (TSX, FSE: “HBP” / OTCQX: “HXBPF”) today announced the appointment of Kazimierz Roszkowski-Śliż, M.D., Ph.D., to its board of directors. Professor Roszkowski-Śliż is replacing Professor Slawomir Majewski, who has stepped down from the board to assume the advisory role of European medical director for Helix.